Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities (The San Francisco Examiner)
CORONA, Calif. ( Map ) - CORONA, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration ("FDA") has initiated an inspection of the company's Florida facilities.

Diamyd Medical: Diamyd Updates FDA IND Approval Status For Phase III Diamyd(R) Diabetes Study In The US (Medical News Today)
Diamyd Medical (NASDAQ:DMYDY) (STO:DIAMB) announced that it has received one FDA question relating to the US Phase III IND application for Diamyd in treatment of type 1 diabetes. The question has been answered with additional documentation and the FDA now has 30 days to respond.